These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Use of splenin for correcting lipid metabolic disorders in systemic connective tissue diseases]. Kishko AS Vrach Delo; 1982 Feb; (2):79-81. PubMed ID: 7064461 [No Abstract] [Full Text] [Related]
5. [Use of splenin in the combined treatment of pulmonary tuberculosis patients]. Spesivtsev OG; Gal'chanskaia LD; Sobolevskaia LI; Prosvetov IuV Probl Tuberk; 1985; (8):28-31. PubMed ID: 4059204 [No Abstract] [Full Text] [Related]
6. [Levamisole and splenin in combined therapy of patients with bronchiectasis]. Sokhin AA; Monogarova NE; Zeligman VS; Chernykh SN; Radugina GS Klin Med (Mosk); 1989 Sep; 67(9):38-41. PubMed ID: 2586038 [TBL] [Abstract][Full Text] [Related]
7. [Use of trasylol in diabetic ketoacidosis]. Zelinskiĭ BA; Kogut ES Vrach Delo; 1976 Sep; (9):78-80. PubMed ID: 824820 [No Abstract] [Full Text] [Related]
8. [Splenin therapy of patients with acute infectious hepatitis]. Verzhkhovskaia AA Vrach Delo; 1966 Mar; 3():106-10. PubMed ID: 5990007 [No Abstract] [Full Text] [Related]
9. [The immunomodulating action of vilozen and splenin in angina patients against a background of chronic bronchitis]. Frolov VM; Peresadin NA; Ershova IB; Demenkov VR; Miakina AV Lik Sprava; 1992 Aug; (8):79-81. PubMed ID: 1475936 [TBL] [Abstract][Full Text] [Related]
10. [Effect of splenin on the development of experimental inflammation in rats]. Shevchenko AV; Korpachev VV Fiziol Zh (1978); 1983; 29(4):489-91. PubMed ID: 6687342 [No Abstract] [Full Text] [Related]
11. [Comparative evaluation of 2 regimens of low-dose insulin therapy in diabetic ketoacidosis]. Demin AA; Zhuk RD; Koromal'di GG Ter Arkh; 1982; 54(9):81-3. PubMed ID: 6817434 [No Abstract] [Full Text] [Related]
12. [The efficacy of immunomodulating therapy in patients with chronic cholestatic liver diseases]. Petrunia AM; Enenko IuA Lik Sprava; 1996; (3-4):125-7. PubMed ID: 9035846 [TBL] [Abstract][Full Text] [Related]
13. [Effect of splenin on protein-synthetising function of the liver during treatment of experimental tuberculosis with large doses of isoniazid]. Afrikanov II; Il'inykh AP Probl Tuberk; 1975; (7):74-8. PubMed ID: 1215372 [No Abstract] [Full Text] [Related]
14. [Effect of levamisole, splenin and thymosterin A on the immunocompetent cells of tuberculosis patients]. Kogosova LS; Chernushenko EF; Petrashenko AI Probl Tuberk; 1982 May; (5):60-4. PubMed ID: 7111259 [No Abstract] [Full Text] [Related]
15. [Use of splenin in clinical medicine (review of the literature)]. Gandzha IM; Lysenko GI; Kishko AS Vrach Delo; 1983 Jun; (6):9-15. PubMed ID: 6353761 [No Abstract] [Full Text] [Related]
16. [Effect of Splenin on certain metabolic indices in patients with atherosclerosis]. Golovtsev IuN Ter Arkh; 1969 Sep; 41(9):66-70. PubMed ID: 5396454 [No Abstract] [Full Text] [Related]
17. [Acid-base state indices in diabetes mellitus under comprehensive treatment with the use of the preparation, carbostimulin]. Shcherbak AV; Iavorskiĭ LA; Litvinenko VV; Zubkova ST Vrach Delo; 1980 Apr; (4):85-8. PubMed ID: 6770545 [No Abstract] [Full Text] [Related]
18. Diabetic ketoacidosis with clozapine treatment. Maule S; Giannella R; Lanzio M; Villari V Diabetes Nutr Metab; 1999 Apr; 12(2):187-8. PubMed ID: 10554900 [No Abstract] [Full Text] [Related]
19. [Infusion of simple insulin in low doses in the management of diabetic ketoacidosis. Experience with 140 cases]. Santos M; Ovalle F; García R Rev Invest Clin; 1982; 34(2):99-103. PubMed ID: 6812191 [No Abstract] [Full Text] [Related]
20. [Use of sulfhydryl-group donors in the complex treatment of diabetic ketoacidosis]. Zelinskiĭ BA; Goncharov LI; Gamarnik LV Ter Arkh; 1981; 53(4):132-3. PubMed ID: 6789488 [No Abstract] [Full Text] [Related] [Next] [New Search]